Chart 1.

Distribution of the individual characteristics of each patient from Group 1 (n = 19).

	Gender	Age	Anatomical Location	Staging	Fractioned dose	Total dose	Treatment volume
1	M	66	Parotid	T4N0M0	2,0	60,0	768
2	M	64	Larynx	T4N0M0	1,8	70,2	1.261
3	M	73	Oropharynx	T4N3M0	1,8	70,2	2.828
4	M	62	Larynx	T3N0M0	2,0	72,0	1.562
5	M	66	Parotid	T1N1M0	2,0	60,0	1.411
6	M	59	Oropharynx	T2N3M0	1,8	72,0	2.608
7	M	52	Larynx	T2N0M0	2,0	66,0	1.664
8	M	45	Oropharynx	T3N0M0	2,0	60,0	992
9	M	52	Oropharynx	T4N0M0	1,8 −2,0	61,0	1.930
10	M	64	Oropharynx	T2N1M0	1,8	61,2	1875
11	M	66	Larynx	T4N2M0	2,0	72,0	2.044
12	M	77	Larynx	T2N0M0	1,8	66,6	1.822
13	M	74	Larynx	T4N3M0	1,8	72,0	1.980
14	M	58	Oropharynx	T2N0M0	2,0	60,0	1.605
15	M	78	Larynx	T4N0M0	2,0	64,0	1.060
16	M	58	Larynx	T4N0M0	1,8	60,0	1.597
17	M	76	Hypopharynx	T2N0M0	1,8 −2,0	72,0	2.400
18	M	82	Oropharynx	T2N1M0	2,0	62,0	1.905
19	M	37	Larynx	T2N0M0	1,8	66,6	1.822